Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | XENE |
---|---|---|
09:32 ET | 1739 | 41.05 |
09:50 ET | 200 | 41.36 |
09:52 ET | 300 | 41.63 |
09:56 ET | 100 | 41.515 |
09:57 ET | 100 | 41.63 |
10:01 ET | 1410 | 41.47 |
10:03 ET | 271 | 41.23 |
10:06 ET | 200 | 41.43 |
10:17 ET | 100 | 41.41 |
10:21 ET | 420 | 41.495 |
10:24 ET | 1035 | 41.69 |
10:26 ET | 100 | 41.68 |
10:28 ET | 300 | 41.76 |
10:30 ET | 1312 | 41.94 |
10:37 ET | 1059 | 41.885 |
10:39 ET | 400 | 41.9 |
10:42 ET | 4184 | 42.01 |
10:44 ET | 400 | 42.12 |
10:48 ET | 2723 | 41.945 |
10:50 ET | 2612 | 41.72 |
10:55 ET | 2277 | 41.59 |
10:57 ET | 300 | 41.58 |
11:00 ET | 200 | 41.67 |
11:04 ET | 300 | 41.6 |
11:06 ET | 200 | 41.575 |
11:08 ET | 28149 | 41.4 |
11:09 ET | 1124 | 41.375 |
11:13 ET | 200 | 41.4 |
11:15 ET | 1966 | 41.405 |
11:18 ET | 609 | 41.46 |
11:20 ET | 200 | 41.405 |
11:22 ET | 100 | 41.41 |
11:24 ET | 2716 | 41.38 |
11:26 ET | 163 | 41.415 |
11:27 ET | 144 | 41.415 |
11:29 ET | 1800 | 41.35 |
11:31 ET | 12183 | 41.23 |
11:33 ET | 1463 | 41.345 |
11:36 ET | 147 | 41.37 |
11:38 ET | 148 | 41.37 |
11:40 ET | 246 | 41.44 |
11:44 ET | 300 | 41.43 |
11:45 ET | 370 | 41.375 |
11:47 ET | 100 | 41.37 |
11:49 ET | 200 | 41.42 |
11:54 ET | 380 | 41.355 |
12:00 ET | 300 | 41.38 |
12:02 ET | 100 | 41.345 |
12:05 ET | 100 | 41.38 |
12:09 ET | 820 | 41.43 |
12:12 ET | 100 | 41.505 |
12:18 ET | 1132 | 41.47 |
12:20 ET | 1099 | 41.51 |
12:21 ET | 200 | 41.61 |
12:23 ET | 700 | 41.615 |
12:30 ET | 2068 | 41.6225 |
12:32 ET | 1000 | 41.665 |
12:34 ET | 100 | 41.645 |
12:36 ET | 2393 | 41.565 |
12:39 ET | 2405 | 41.5125 |
12:41 ET | 600 | 41.57 |
12:43 ET | 200 | 41.53 |
12:45 ET | 2666 | 41.5 |
12:48 ET | 284 | 41.5 |
12:50 ET | 100 | 41.375 |
12:54 ET | 406 | 41.36 |
12:56 ET | 13932 | 41.255 |
12:57 ET | 300 | 41.2 |
12:59 ET | 900 | 41.15 |
01:01 ET | 1785 | 41.25 |
01:03 ET | 3145 | 41.25 |
01:06 ET | 450 | 41.31 |
01:08 ET | 2963 | 41.25 |
01:12 ET | 400 | 41.23 |
01:17 ET | 7674 | 41.21 |
01:19 ET | 200 | 41.05 |
01:21 ET | 700 | 41.025 |
01:26 ET | 1494 | 41.12 |
01:30 ET | 100 | 41.07 |
01:33 ET | 508 | 41.08 |
01:35 ET | 1006 | 41.1 |
01:39 ET | 100 | 41.1 |
01:44 ET | 282 | 41.08 |
01:46 ET | 418 | 41.11 |
01:50 ET | 1111 | 41.25 |
01:51 ET | 100 | 41.3 |
01:55 ET | 100 | 41.255 |
01:57 ET | 2507 | 41.305 |
02:00 ET | 4352 | 41.23 |
02:02 ET | 100 | 41.235 |
02:06 ET | 400 | 41.25 |
02:09 ET | 7701 | 41.22 |
02:11 ET | 500 | 41.225 |
02:15 ET | 300 | 41.24 |
02:18 ET | 600 | 41.28 |
02:20 ET | 1198 | 41.28 |
02:22 ET | 304 | 41.27 |
02:24 ET | 1819 | 41.22 |
02:26 ET | 300 | 40.955 |
02:29 ET | 200 | 41.03 |
02:31 ET | 4336 | 41.02 |
02:33 ET | 218 | 41.04 |
02:36 ET | 900 | 41.07 |
02:38 ET | 400 | 41.11 |
02:40 ET | 200 | 41.085 |
02:42 ET | 100 | 41.06 |
02:45 ET | 400 | 41.05 |
02:47 ET | 100 | 41.02 |
02:49 ET | 100 | 41.03 |
02:51 ET | 200 | 41.05 |
02:58 ET | 2157 | 41.02 |
03:00 ET | 741 | 41.02 |
03:02 ET | 198 | 41.03 |
03:03 ET | 3760 | 41 |
03:05 ET | 308 | 41 |
03:07 ET | 6974 | 40.74 |
03:09 ET | 300 | 40.77 |
03:14 ET | 1100 | 40.795 |
03:16 ET | 900 | 40.895 |
03:18 ET | 820 | 40.89 |
03:21 ET | 411 | 40.815 |
03:23 ET | 100 | 40.74 |
03:30 ET | 100 | 40.8 |
03:32 ET | 108 | 40.785 |
03:34 ET | 100 | 40.775 |
03:36 ET | 108 | 40.76 |
03:39 ET | 100 | 40.73 |
03:41 ET | 900 | 40.82 |
03:43 ET | 3446 | 40.57 |
03:45 ET | 100 | 40.555 |
03:48 ET | 500 | 40.4901 |
03:50 ET | 337 | 40.58 |
03:52 ET | 4255 | 40.68 |
03:54 ET | 200 | 40.74 |
03:56 ET | 1829 | 40.56 |
03:57 ET | 4204 | 40.525 |
03:59 ET | 23356 | 40.48 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Xenon Pharmaceuticals Inc | 3.1B | -14.9x | --- |
Iovance Biotherapeutics Inc | 3.0B | -6.0x | --- |
SpringWorks Therapeutics Inc | 3.1B | -8.1x | --- |
Biohaven Ltd | 3.0B | -4.9x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Apogee Therapeutics Inc | 3.0B | -30.4x | --- |
Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.1B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 75.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.25 |
EPS | $-2.71 |
Book Value | $12.31 |
P/E Ratio | -14.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.